Provided by Tiger Trade Technology Pte. Ltd.

Altimmune, Inc.

3.50
-0.1000-2.78%
Post-market: 3.500.0026+0.07%19:59 EDT
Volume:3.12M
Turnover:10.99M
Market Cap:455.25M
PE:-3.50
High:3.68
Open:3.62
Low:3.47
Close:3.60
52wk High:7.73
52wk Low:2.90
Shares:130.07M
Float Shares:124.00M
Volume Ratio:0.77
T/O Rate:2.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9999
EPS(LYR):-0.9999
ROE:-50.57%
ROA:-28.17%
PB:2.02
PE(LYR):-3.50

Loading ...

Altimmune Q3 revenue beats expectations

Reuters
·
Nov 06, 2025

Altimmune Q3 Basic EPS USD -0.21

THOMSON REUTERS
·
Nov 06, 2025

Altimmune Announces Third Quarter 2025 Financial Results and Business Updates

THOMSON REUTERS
·
Nov 06, 2025

Immunocore reports third quarter financial results and provides a business update

GlobeNewswire
·
Nov 06, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 06, 2025

Altimmune Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

Syndax Announces Compelling Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Data Accepted for Presentation at ASH 2025

GlobeNewswire
·
Nov 03, 2025

Altimmune Announces Early Completion of Enrollment in Reclaim Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder

THOMSON REUTERS
·
Nov 03, 2025

Metsera the US obesity biotech at centre of Novo, Pfizer bidding war

Reuters
·
Oct 31, 2025

H.C. Wainwright Sticks to Their Buy Rating for Altimmune (ALT)

TIPRANKS
·
Oct 29, 2025

PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

GlobeNewswire
·
Oct 24, 2025

Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 20, 2025

BUZZ-U.S. STOCKS ON THE MOVE- SLB NV, Bank OZK, Gilead Sciences

Reuters
·
Oct 18, 2025

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

GlobeNewswire
·
Oct 15, 2025

ANDE Smart Supply Chain Sees Surge in Bank Loans: Backed by Midea with Billions in Related Transactions Annually, Continues Dividends of Nearly 600 Million

Deep News
·
Oct 14, 2025

Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 10, 2025

Altimmune Inc. Files Initial Beneficial Ownership Statement for Chief Medical Officer Christophe Arbet-Engels

Reuters
·
Oct 04, 2025

Altimmune Appoints Christophe Arbet-Engels as Chief Medical Officer; Dr. Scott Harris to Transition to Senior Strategic Advisor Ahead of 2026 Retirement

Reuters
·
Oct 04, 2025

Altimmune Inc. Faces Class Action Lawsuit Over Alleged Securities Fraud Filed by Shareholders

Reuters
·
Oct 01, 2025

ALT Resources PLC Announces General Meeting to Amend Articles of Association

TIPRANKS
·
Oct 01, 2025